LOIS SWAIN: Open Payments
NPI 1992211676 · LEESVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$359 in 16 payments from 6 companies in 2025. Trend: 2023 $84 · 2024 $48 · 2025 $359
Food & beverage: $359
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 4 | $104 |
| ABBVIE INC. | 4 | $93 |
| Axsome Therapeutics, Inc. | 4 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Alkermes, Inc. | 1 | $20 |
Products named: SUBLOCADE, VRAYLAR, Auvelity, CAPLYTA, ABILIFY MAINTENA, ARISTADA.
Industry payments across LA — which companies pay providers there.
